HRF at a Glance
The experts at Hippocrates Research Foundation have years of experience successfully reversing chronic diseases when standard of care medicine has failed. Most chronic diseases can be traced back to mitochondrial dysfunction and insufficient cellular energy production. Through thousands of years of evolution the human body has been hardwired to heal itself if adequate amounts of energy are available. Proper diet, exercise, supplements, pulsed electromagnetic fields, red light therapy and hyperbaric oxygen are a few of the metabolic interventions proven to improve mitochondrial function and energy production. The criteria for interventions at HRF is “First do no Harm.”
At Hippocrates Research Foundation, we believe a durable remission—or cure—for cancer is within reach.
The abscopal effect, in which treatment of one tumor triggers the immune system to attack cancer throughout the body, represents one of the most promising pathways to lasting remission. While historically rare and unpredictable, we are working to change that.
Today, patients have access to remarkable FDA-approved ablative technologies: Histotripsy for liver cancer and metastatic disease to the liver, High-Intensity Focused Ultrasound (HIFU) for prostate cancer, and Pulsed Electric Field therapy—which received FDA Breakthrough Device designation in 2018—for stage 3 pancreatic cancer. These treatments can effectively destroy tumors, but they very rarely achieve the abscopal effect on their own.
The Abscopal Effect Initiative
HRF emphasizes timing: Optimizing the immune system before ablation (via lab testing + AI) increases systemic anti-cancer response likelihood. FDA-approved ablative technologies include Histotripsy (non-invasive ultrasound for liver tumors, FDA-approved 2023), Pulsed Electric Field Therapy (for stage 3 pancreatic cancer), and HIFU (for prostate cancer).
Molecular Hydrogen & Deuterium Depletion
Hydrogen acts as an antioxidant, enhancing mitochondrial function. Deuterium (heavy hydrogen) correlates with chronic disease; lowering it improves cellular health. HRF proposes alternatives to the costly Press-Pulse Protocol using hydrogen/deuterium modulation.
Mitochondrial-Stem Cell Connection
A September 2024 study proposed targeting oxidative insufficiency in stem cells as a cancer origin theory. Therapies include orthomolecules (Vitamin C/D, zinc), pharmaceuticals (Ivermectin, benzimidazoles), and lifestyle changes (ketogenic diet, hyperbaric oxygen, physical activity).
HRF’s Goals
Clinical Validation: Raise funds for staff/trials to validate protocols. Global Impact: Aspire to expand access via certified healthcare professionals, avoiding chemotherapy/radiation when possible.
The information provided on this website is for educational and research purposes only, and does not substitute for professional medical advice. You should consult your physician or health care professional to determine if any of the information is right for your unique needs.
Contact: drhoward@myhrf.org | 9002 Six Pines Dr, Shenandoah, Texas 77380